SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending after delivering exceptional financial results that paradoxically led to a notable stock decline, sparking community debate over market manipulation, "sell the news" reactions, and the sustainability of AI-driven demand across the broader tech sector.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is surging following better-than-expected financial results, reporting a surprise Q4 profit and raising revenue guidance, signaling a significant operational turnaround. The community is buzzing about new oncology and expanded infectious disease agreements leveraging its Matrix-M adjuvant technology, which combined with high short interest, is fueling strong short squeeze sentiment and excitement for future partnerships.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is trending after a substantial earnings miss and weak guidance led to a significant stock drop, causing widespread community distrust in management, though some investors see it as an oversold opportunity in the growing energy storage sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is surging following its strong Q4 revenue beat, raised 2026 guidance, and major contract awards like the $151 billion SHIELD defense program, fueling intense community debate between bullish investors anticipating a short squeeze and skeptics highlighting ongoing losses and high valuation.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending after reporting strong recent earnings that showcased robust growth and distribution expansion through Pepsi, yet the stock has experienced significant volatility, sparking community debate over CEO John Fieldly's leadership and the impact of broader market conditions.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is experiencing extreme volatility as federal approval to restart its Santa Ynez pipeline clashes with ongoing lawsuits from California environmental groups and the state. The community fiercely debates whether federal preemption will lead to a significant short squeeze or if persistent regulatory hurdles, a recent stock offering, and an ongoing SEC investigation will ultimately hinder operations.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending after reporting strong quarterly financial results and significant share repurchases, yet community sentiment remains divided as the stock's price reaction is muted, fueling frustration over management's communication and ongoing speculation about the AUR200 pipeline and a potential buyout.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is trending due to significant volatility following FDA feedback suggesting its Huntington's disease gene therapy, AMT-130, lacks sufficient Phase I/II data for accelerated approval. This has ignited fervent community discussion about the FDA's shifting regulatory landscape and whether recent critical comments were even directed at QURE, as the company prepares for a crucial Type A meeting to determine a path forward.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is at the center of investor discussion following its recent earnings, which highlighted a stable balance sheet and international growth amidst persistent challenges for its BetterHelp segment. This has polarized the community, with bulls seeing a deeply undervalued stock ready for a short squeeze, while bears remain skeptical of management's ability to drive sustained profitability in a competitive telehealth market.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is surging as the community keenly watches its response to Paramount Global's raised bid for Warner Bros. Discovery, with many shareholders actively advocating for Netflix to abandon the deal and secure a significant breakup fee, expecting this outcome to be highly bullish amid ongoing regulatory and political headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Ives maintained an ‘Outperform’ rating on the stock.&nbsp;</li><li>Wedbush sees 2026 as a significant year for Rivian, with the SUV launch expected to boost delivery metrics and the autonomy roadmap, boosting alternative revenue sources.</li><li>On Thursday, Baird upgraded Rivian to ‘Outperform’ from ‘Neutral’ and also increased its target price to $25 per share from $14.</li></ul>Wedbush Managing Director and Senior Equity Research Analyst Daniel Ives raised Rivian Automotive Inc.’s (<a href="https://stocktwits.com/symbol/RIVN">RIVN</a>) price target to $25 from $16 with an ‘Outperform’ rating on Friday, citing the company’s expected R2 launch and autonomy roadmap.Ives noted that they believe 2026 would be a significant year for Rivian given its new SUV launch, which would boost delivery metrics, according to TheFly. Rivian’s new autonomy roadmap would help the automaker tap into alternative revenue sources while also managing costs related to tariffs and business investments, he added.<h2 class="st-heading-2">Recent Street Action</h2>On Thursday, Baird upgraded Rivian to ‘Outperform’ from ‘Neutral’ and also increased its target price to $25 per share from $14. Last week, Goldman Sachs increased Rivian’s price target to $16 from $13 while maintaining a ‘Neutral’ rating, while Needham maintained a ‘Buy’ rating, raising the price to $23 from $14.The analyst action comes amid increased confidence in Rivian’s new SUV, the R2 model, expected to launch in 2026. Earlier this month, the car maker also made a series of announcements at its AI and autonomy event, including the development of its custom chip, RAP1 (Rivian Autonomy Processor 1), which would help it achieve level 4 vehicle autonomy, as well as an Autonomy+ subscription for its next-gen customers.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, RIVN was among the top trending stocks on Friday morning. The retail sentiment around RIVN remained in the ‘bullish’ territory over the past 24 hours, and message volume stayed at ‘extremely high’ levels at the time of writing.<figure class="image"><img style="aspect-ratio:1281/153;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_19_at_6_12_47_PM_png_c6f02bed9c.webp" alt="On Stocktwits, The retail sentiment around RIVN remained in the ‘bullish’ territory over the past 24 hours, and message volume stayed at ‘extremely high’ levels at the time of writing." width="1281" height="153"></figure>One Stocktwits user highlighted the upgrade and said that they expected the price to rise above $25.<stembedurl>https://stocktwits.com/Chevmantm/message/639670880</stembedurl>Another user opined that they expect the stock to hit $100 soon.<stembedurl>https://stocktwits.com/Johamfly/message/639668215</stembedurl>Shares of RIVN are up over 53% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

A Rivian charges outside of Blink Charging's new flagship manufacturing facility in Bowie, Md., on Monday March 11, 2024. (Tom Williams/CQ-Roll Call, Inc via Getty Images)

Dan Ives Raises His Price Target On Rivian – Why Does He Expect 2026 To Be A Significant Year For The Company?

Ives raised Rivian’s price target to $25 from $16, citing the company’s R2 launch and autonomy roadmap in 2026.

Equity

Ives raised Rivian’s price target to $25 from $16, citing the company’s R2 launch and autonomy roadmap in 2026. 

AVES
American Century ETF Trust - Avantis Emerging Markets Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest AVES News

AVESAmerican Century ETF Trust - Avantis Emerging Markets Value ETF